Clinical Trial Update: Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating recovery from acute immune failure in septic shock using immune cell extracorporeal therapy; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Snippet

Sponsor: Artcline GmbH | Conditions: Sepsis, Severe | Phase 2 | Status: RECRUITING